STEPHEN PAPPAS

Concepts (66)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hepatorenal Syndrome
12
2025
34
2.780
Why?
Vasoconstrictor Agents
11
2025
147
1.220
Why?
Lypressin
9
2025
19
0.980
Why?
Hepatitis B
1
2021
172
0.650
Why?
Duty to Warn
1
2019
2
0.620
Why?
Professional Impairment
1
2019
3
0.610
Why?
Alcoholic Intoxication
1
2019
11
0.610
Why?
Confidentiality
1
2019
106
0.570
Why?
Hepatitis C Antibodies
1
2017
24
0.560
Why?
Kidney Function Tests
2
2017
132
0.550
Why?
Alcoholism
1
2019
252
0.500
Why?
Diagnostic Tests, Routine
1
2017
135
0.500
Why?
Hepacivirus
1
2017
273
0.480
Why?
Albumins
6
2023
99
0.440
Why?
Liver Cirrhosis
5
2023
947
0.240
Why?
Acute Kidney Injury
2
2025
706
0.230
Why?
Bradycardia
1
2025
62
0.230
Why?
Liver Transplantation
3
2023
1124
0.210
Why?
Respiratory Insufficiency
2
2022
240
0.200
Why?
Hepatitis, Alcoholic
1
2023
36
0.190
Why?
Hepatitis B Antibodies
1
2021
24
0.180
Why?
Arrhythmias, Cardiac
1
2025
475
0.180
Why?
Hepatitis B Vaccines
1
2021
45
0.180
Why?
Acute-On-Chronic Liver Failure
1
2022
83
0.170
Why?
Hepatitis B virus
1
2021
140
0.170
Why?
Liver Cirrhosis, Alcoholic
1
2019
40
0.150
Why?
Safety
1
2019
217
0.140
Why?
Hepatic Encephalopathy
1
2019
94
0.140
Why?
Drug Therapy
1
2017
93
0.130
Why?
Humans
16
2025
133373
0.130
Why?
Health Personnel
1
2021
549
0.130
Why?
Alcohol Drinking
1
2019
362
0.120
Why?
Self Report
1
2019
553
0.120
Why?
Patient Education as Topic
1
2019
467
0.120
Why?
Surgical Procedures, Operative
1
2017
194
0.120
Why?
Interdisciplinary Communication
1
2016
134
0.110
Why?
Systemic Inflammatory Response Syndrome
1
2016
198
0.110
Why?
Interprofessional Relations
1
2016
156
0.110
Why?
Hepatitis C
1
2017
387
0.100
Why?
Information Dissemination
1
2016
199
0.100
Why?
Metabolomics
1
2017
471
0.100
Why?
Gastrointestinal Diseases
1
2016
353
0.090
Why?
Clinical Trials, Phase III as Topic
2
2025
77
0.090
Why?
Disease Progression
1
2017
2246
0.090
Why?
Renal Replacement Therapy
2
2023
159
0.090
Why?
Treatment Outcome
6
2023
13103
0.080
Why?
Biomarkers
1
2019
3415
0.080
Why?
Physicians
1
2016
640
0.080
Why?
Double-Blind Method
2
2021
1661
0.060
Why?
Randomized Controlled Trials as Topic
2
2025
1214
0.060
Why?
Canada
2
2016
343
0.060
Why?
Middle Aged
6
2025
28985
0.060
Why?
Drug Therapy, Combination
2
2017
1165
0.050
Why?
Infusions, Intravenous
1
2021
569
0.040
Why?
Male
6
2025
65592
0.040
Why?
Female
6
2025
71503
0.040
Why?
Aged
3
2025
21500
0.040
Why?
Combined Modality Therapy
1
2021
1310
0.030
Why?
Placebos
1
2016
235
0.030
Why?
Survival Rate
1
2020
2207
0.030
Why?
Adult
3
2025
31684
0.030
Why?
Survival Analysis
1
2016
1584
0.020
Why?
Prognosis
1
2020
5044
0.020
Why?
Kidney
1
2016
1395
0.020
Why?
United States
1
2016
11722
0.010
Why?
Retrospective Studies
1
2016
17568
0.010
Why?
PAPPAS's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (66)
Explore
_
Co-Authors (4)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_